She L, Alanazi H, Xu Y, Yu Y, Gao Y, Guo S
iScience. 2024; 27(11):111240.
PMID: 39563895
PMC: 11574794.
DOI: 10.1016/j.isci.2024.111240.
Fernandes C, Miranda M, Rodrigues Roque C, Paguada A, Mota C, Florencio K
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204125
PMC: 11357004.
DOI: 10.3390/ph17081020.
Li X, Xu H, Du Z, Cao Q, Liu X
Front Oncol. 2024; 14:1382701.
PMID: 38628669
PMC: 11018917.
DOI: 10.3389/fonc.2024.1382701.
Uddin M, Thompson B, Leslie J, Fishman C, Sol-Church K, Kumar P
mBio. 2024; 15(3):e0333823.
PMID: 38376154
PMC: 11209775.
DOI: 10.1128/mbio.03338-23.
Park J, Gazzaniga F, Kasper D, Sharpe A
Exp Mol Med. 2023; 55(9):1913-1921.
PMID: 37696895
PMC: 10545783.
DOI: 10.1038/s12276-023-01075-0.
Unconventional immune cells in the gut mucosal barrier: regulation by symbiotic microbiota.
Yoo J, Oh S
Exp Mol Med. 2023; 55(9):1905-1912.
PMID: 37696893
PMC: 10545787.
DOI: 10.1038/s12276-023-01088-9.
Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity.
Guo Y, Liu Y, Rui B, Lei Z, Ning X, Liu Y
Front Immunol. 2023; 14:1171680.
PMID: 37304260
PMC: 10249960.
DOI: 10.3389/fimmu.2023.1171680.
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors.
Drommi F, Calabro A, Vento G, Pezzino G, Cavaliere R, Omero F
Cancers (Basel). 2023; 15(11).
PMID: 37296855
PMC: 10252007.
DOI: 10.3390/cancers15112893.
Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells.
Lv X, Zhu S, Wu J, Shi J, Wei Q, Li T
Cell Mol Immunol. 2023; 20(7):808-819.
PMID: 37225838
PMC: 10310834.
DOI: 10.1038/s41423-023-01041-w.
strain ZY-312 facilitates colonic mucosa regeneration in colitis motivating STAT3 signaling pathway induced by IL-22 from ILC3 secretion.
Zhang W, Zhou Q, Liu H, Xu J, Huang R, Shen B
Front Immunol. 2023; 14:1156762.
PMID: 37114045
PMC: 10126674.
DOI: 10.3389/fimmu.2023.1156762.
Programmed cell death-1 receptor-mediated regulation of TbetNK1.1 innate lymphoid cells within the tumor microenvironment.
Lim J, Lai C, Mallett G, McDonald D, Hulme G, Laba S
Proc Natl Acad Sci U S A. 2023; 120(18):e2216587120.
PMID: 37098069
PMC: 10161089.
DOI: 10.1073/pnas.2216587120.
Function of Innate Lymphoid Cells in Periodontal Tissue Homeostasis: A Narrative Review.
Ma Z, Wang J, Hu L, Wang S
Int J Mol Sci. 2023; 24(7).
PMID: 37047071
PMC: 10093809.
DOI: 10.3390/ijms24076099.
Reply to 'Reclassification of plasmacytoid dendritic cells as innate lymphocytes is premature'.
Ziegler-Heitbrock L, Ohteki T, Ginhoux F, Shortman K, Spits H
Nat Rev Immunol. 2023; 23(5):338-339.
PMID: 36959480
DOI: 10.1038/s41577-023-00866-w.
Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.
He L, Yang L, Liu T, Li Y, Huang T, Zhang L
Respir Res. 2023; 24(1):90.
PMID: 36949482
PMC: 10033286.
DOI: 10.1186/s12931-023-02395-5.
ILCs-Crucial Players in Enteric Infectious Diseases.
Leupold T, Wirtz S
Int J Mol Sci. 2022; 23(22).
PMID: 36430676
PMC: 9695539.
DOI: 10.3390/ijms232214200.
The thin line between conventional dendritic cells (cDCs) and group 3 innate lymphoid cells (ILC3s) in the gut.
Ulezko Antonova A, Fachi J, Gilfillan S, Colonna M
Int Immunol. 2022; 35(3):107-121.
PMID: 36409583
PMC: 10210749.
DOI: 10.1093/intimm/dxac054.
Signaling Crosstalks Drive Generation and Regeneration of the Thymus.
Rosichini M, Catanoso M, Screpanti I, Felli M, Locatelli F, Velardi E
Front Immunol. 2022; 13:920306.
PMID: 35734178
PMC: 9207182.
DOI: 10.3389/fimmu.2022.920306.
Coordination of Mucosal Immunity by Innate Lymphoid Cells.
Zhou J, Sonnenberg G
Adv Exp Med Biol. 2022; 1365:113-134.
PMID: 35567744
DOI: 10.1007/978-981-16-8387-9_8.
Innate Lymphoid Cells and Inflammatory Bowel Disease.
Peng V, Jaeger N, Colonna M
Adv Exp Med Biol. 2022; 1365:97-112.
PMID: 35567743
DOI: 10.1007/978-981-16-8387-9_7.
Innate Lymphoid Cells: Role in Immune Regulation and Cancer.
Chung D, Jacquelot N, Ghaedi M, Warner K, Ohashi P
Cancers (Basel). 2022; 14(9).
PMID: 35565201
PMC: 9102917.
DOI: 10.3390/cancers14092071.